November 8, 2010

Loss of patent protection for branded drugs and subsequent competition from generics could save the...

September 29, 2010

The Food and Drug Administration has given tentative approval to a generic cholesterol drug made...

September 6, 2010

With September marked as National Cholesterol Education Month, drug maker AstraZeneca is using the occasion...

August 30, 2010

The U.S. drug market will present opportunities as well as uncertainties over the next decade,...

August 23, 2010

Drug advertisements that tie disease risks with family history can influence consumers' choice of medications...

August 23, 2010

Generic drug maker Impax Labs is hoping to win approval for a generic cholesterol-lowering drug....

August 1, 2010

Merck had global sales of $11.3 billion and profits of $752 million during second quarter...

July 18, 2010

Metabolex has entered an agreement to discover and develop Type 2 diabetes drugs with a...

July 6, 2010

Changing generic substitution laws in favor of less-restrictive regulations could save states struggling to pay...

June 20, 2010

A new cholesterol drug made by Eli Lilly and Kowa Pharmaceuticals America has become available,...

June 17, 2010

The Food and Drug Administration has approved a generic cholesterol medication made by Mylan, the...

May 19, 2010

A subsidiary of generic drug maker Watson Pharmaceuticals has launched a version of a cholesterol-lowering...

May 4, 2010

A subsidiary of Watson Pharmaceuticals is challenging the patent to a drug for high cholesterol,...

March 21, 2010

Merck & Co. has responded to a warning by the Food and Drug Administration about...

March 18, 2010

Patients taking a common drug for treating high cholesterol may be at increased risk of...

March 14, 2010

Diabetes patients combining drugs to control blood fat and blood pressure may remain at risk...

March 8, 2010

An organization representing the generic drug industry is hoping that Congress gives the Food and...

February 28, 2010

GlaxoSmithKline has identified more than 5,500 rare diseases it potentially could target as part of...

February 9, 2010

A drug for treating a genetic cholesterol disorder decreased levels of “bad” LDL cholesterol in...

October 18, 2009

What’s really intriguing behind the return of a consumer division to Pfizer is the fact...

January 29, 2009

The deal gives a great deal of added heft to Pfizer’s pharmaceutical division — the...